Merck Hires Julie Gerberding, A Former CDC Chief, To Run Its Vaccine Division
This article was originally published in The Pink Sheet Daily
Executive Summary
The big drug maker hires a high-profile physician with a public-health pedigree to boost its stagnant vaccine division.
You may also be interested in...
Merck Vaccine President Slot Opens Up With McGlynn's Retirement
A consummate Merck insider, Margie McGlynn, announces her plans to retire, as the company prepares for its pending merger with Schering-Plough.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.